← Back to Search

Plain Bupivacaine for Bupivacaine

Phase 4
Waitlist Available
Led By Brian M Fitzgerald, MD
Research Sponsored by Brooke Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up thru 72 hours
Awards & highlights

Study Summary

Randomized double blind placebo controlled trial to compare the post-operative pain control advantages of post-incisional wound infiltration with liposomal bupivacaine to plain bupivacaine in patients presenting for elective caesarean delivery.

Eligible Conditions
  • Bupivacaine
  • Postoperative Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~thru 72 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and thru 72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Post-operative Analgesia
Secondary outcome measures
Breast
Increased operative time
Length of Stay (LOS)
+5 more

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: Plain BupivacaineExperimental Treatment1 Intervention
Subject will receive 20ml of 0.5% plain bupivacaine infiltration (100mg)
Group II: Liposomal BupivacaineExperimental Treatment1 Intervention
Subject will receive 20ml of liposomal bupivacaine infiltration (266mg) non-expanded
Group III: Normal SalinePlacebo Group1 Intervention
Subject will receive 20ml of normal saline infiltration
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved
Bupivacaine
FDA approved

Find a Location

Who is running the clinical trial?

Brooke Army Medical CenterLead Sponsor
119 Previous Clinical Trials
26,427 Total Patients Enrolled
Brian M Fitzgerald, MDPrincipal InvestigatorBrooke Army Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Wound Infiltration of Liposomal Bupivacaine v Plain Bupivacaine for Post-Op Pain Control in Elective Cesarean Delivery
Brian M. Fitzgerald, MD 2017. "Wound Infiltration of Liposomal Bupivacaine v Plain Bupivacaine for Post-Op Pain Control in Elective Cesarean Delivery". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03353363.
All > Exparel
~18 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top